
Axis Innovation Fund(G)-Direct Plan
+11.09%
5Y annualised
+11.09%
5Y annualised
-0.08% 1D
Expert Rating Locked 🔒
Subscribe to unlock the ratings
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Mattis eget etiam curabitur a cras malesuada pulvinar.
Buy, Hold or Sell?
Unlock our SEBI-RIA verdict on this fund.

NAV : 13 Nov 2026
₹23.90
Min. SIP amount
₹100
Fund size (AUM)
1314 Cr
Expense ratio
1.3%
Launched on
24 Dec 2020
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
NAV : 13 Nov 2026
₹23.90
Min. SIP amount
₹100
Fund size (AUM)
1314 Cr
Expense ratio
1.3%
Launched on
24 Dec 2020
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
SIP Calculator + Returns
Monthly investment
₹8,000
Stock Allocation
Fund Composition
Large Cap
15.47%
Mid Cap
22.92%
Small Cap
34.77%
Others
26.84%
Sector Allocation
Domestic Equities
21.36%
Retailing
11.85%
Overseas Equities
11.31%
Chemicals
7.19%
Cash & Cash Equivalents And Net Assets
7.03%
It
6.61%
Automobile & Ancillaries
5.96%
Capital Goods
4.95%
Others
22.92%
Minimum investments
Returns vs rankings
Exit load, stamp duty and tax
Exit load
Nil for 10% of investment and 1% for remaining investment on or before 12M, Nil after 12M
No exit load after holding period
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within less than 1 year, returns are taxed as per your Income Tax slab. If you redeem after more than 1 year, returns are taxed at 12.5%.
Fund management
Ashish Naik
Present
Krishnaa N
Present
Pratik Tibrewal
Present
Similar/Peer Fund Comparison
ICICI Pru Strategic Metal and Energy Equity FoF(G)-Direct Plan
Kotak Healthcare Fund(G)-Direct Plan
HDFC Pharma and Healthcare Fund(G)-Direct Plan
Mirae Asset Healthcare Fund(G)-Direct Plan
Edelweiss Recently Listed IPO Fund(G)-Direct Plan
SBI Automotive Opportunities Fund(G)-Direct Plan
WOC Pharma and Healthcare Fund(G)-Direct Plan
PGIM India Healthcare Fund(G)-Direct Plan
FAQs
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.
